HUM:NYE-Humana Inc (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 310.41

Change

-1.59 (-0.51)%

Market Cap

N/A

Volume

1.83M

Analyst Target

USD 448.08
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

-2.07 (-0.36%)

USD 532.88B
ELV Elevance Health Inc

+1.86 (+0.35%)

USD 125.09B
CNC Centene Corp

-0.02 (-0.03%)

USD 39.78B
MOH Molina Healthcare Inc

+1.51 (+0.43%)

USD 20.81B
OSCR Oscar Health Inc

-0.34 (-1.46%)

USD 5.30B
NEUE NeueHealth Inc

-0.03 (-0.56%)

USD 0.05B
CI Cigna Corp

-1.12 (-0.31%)

N/A
CVS CVS Health Corp

-0.89 (-1.52%)

N/A

ETFs Containing HUM

SSPX Janus Henderson U.S. Sust.. 3.11 % 0.00 %

-0.21 (-0.64%)

USD 8.87M
TUSB:CA TD Select U.S. Short Term.. 2.16 % 0.28 %

-0.01 (-0.64%)

CAD 8.82M
TUSB-U:CA TD Select U.S. Short Term.. 2.16 % 0.00 %

N/A

CAD 8.25M
SRHQ Elevation Series Trust - .. 1.84 % 0.00 %

-0.08 (-0.64%)

N/A
CVMC Morgan Stanley ETF Trust .. 0.50 % 0.00 %

-0.38 (-0.64%)

N/A
FUM:CA 0.00 % 0.80 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

-0.20 (-0.64%)

N/A
MUS:CA Mackenzie Maximum Diversi.. 0.00 % 0.58 %

-0.12 (-0.64%)

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

-0.73 (-0.64%)

N/A
DUSA 0.00 % 0.63 %

N/A

N/A
DWLD 0.00 % 0.64 %

N/A

N/A
VETS 0.00 % 0.60 %

N/A

N/A
XSGI:LSE Xtrackers S&P Global Infr.. 0.00 % 0.00 %

+3.00 (+-0.64%)

USD 0.25B
XSSX:LSE Xtrackers - Euro Stoxx 50.. 0.00 % 0.00 %

+7.40 (+-0.64%)

USD 0.05B
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
LONG:CA CI Global Longevity Econo.. 0.00 % 0.00 %

N/A

CAD 3.76M
GBLO 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -32.20% 13% F 6% D-
Dividend Return 0.39% 20% F 7% C-
Total Return -31.81% 13% F 6% D-
Trailing 12 Months  
Capital Gain -37.17% 13% F 5% F
Dividend Return 0.72% 20% F 8% B-
Total Return -36.46% 13% F 5% F
Trailing 5 Years  
Capital Gain 11.95% 33% F 52% F
Dividend Return 5.36% 25% F 16% F
Total Return 17.31% 33% F 43% F
Average Annual (5 Year Horizon)  
Capital Gain 5.02% 38% F 56% F
Dividend Return 5.72% 25% F 50% F
Total Return 0.70% 40% F 16% F
Risk Return Profile  
Volatility (Standard Deviation) 19.96% 63% D 52% F
Risk Adjusted Return 28.64% 25% F 47% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector